Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release

被引:149
作者
Ruan, Shaobo [1 ,2 ,3 ]
Zhou, Yang [1 ,2 ]
Jiang, Xinguo [4 ]
Gao, Huile [1 ,2 ]
机构
[1] Sichuan Univ, West China Sch Pharm, Key Lab Drug Targeting & Drug Delivery Syst, Educ Minist,Sichuan Engn Lab Plant Sourced Drug, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Sch Pharm, Sichuan Res Ctr Drug Precis Ind Technol, Chengdu 610041, Peoples R China
[3] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
[4] Fudan Univ, Sch Pharm, Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
brain‐ targeting; drug delivery; dual‐ intracellular trafficking; stimulus‐ responsive; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; TUMOR MICROENVIRONMENT; ACETYLCHOLINE-RECEPTOR; ALZHEIMERS-DISEASE; MEDIATED TRANSPORT; PARKINSONS-DISEASE; GOLD NANOPARTICLES; ISCHEMIC-STROKE; SURFACE-DENSITY;
D O I
10.1002/advs.202004025
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The past decades have witnessed great progress in nanoparticle (NP)-based brain-targeting drug delivery systems, while their therapeutic potentials are yet to be fully exploited given that the majority of them are lost during the delivery process. Rational design of brain-targeting drug delivery systems requires a deep understanding of the entire delivery process along with the issues that they may encounter. Herein, this review first analyzes the typical delivery process of a systemically administrated NPs-based brain-targeting drug delivery system and proposes a six-step CRITID delivery cascade: circulation in systemic blood, recognizing receptor on blood-brain barrier (BBB), intracellular transport, diseased cell targeting after entering into parenchyma, internalization by diseased cells, and finally intracellular drug release. By dissecting the entire delivery process into six steps, this review seeks to provide a deep understanding of the issues that may restrict the delivery efficiency of brain-targeting drug delivery systems as well as the specific requirements that may guarantee minimal loss at each step. Currently developed strategies used for troubleshooting these issues are reviewed and some state-of-the-art design features meeting these requirements are highlighted. The CRITID delivery cascade can serve as a guideline for designing more efficient and specific brain-targeting drug delivery systems.
引用
收藏
页数:27
相关论文
共 206 条
[1]   Structure and function of the blood-brain barrier [J].
Abbott, N. Joan ;
Patabendige, Adjanie A. K. ;
Dolman, Diana E. M. ;
Yusof, Siti R. ;
Begley, David J. .
NEUROBIOLOGY OF DISEASE, 2010, 37 (01) :13-25
[2]   First-in-human trial of blood-brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound [J].
Abrahao, Agessandro ;
Meng, Ying ;
Llinas, Maheleth ;
Huang, Yuexi ;
Hamani, Clement ;
Mainprize, Todd ;
Aubert, Isabelle ;
Heyn, Chinthaka ;
Black, Sandra E. ;
Hynynen, Kullervo ;
Lipsman, Nir ;
Zinman, Lorne .
NATURE COMMUNICATIONS, 2019, 10 (1)
[3]   Ovarian cancer: Strategies for overcoming resistance to chemotherapy [J].
Agarwal, R ;
Kaye, SB .
NATURE REVIEWS CANCER, 2003, 3 (07) :502-516
[4]   CAR T cells for brain tumors: Lessons learned and road ahead [J].
Akhavan, David ;
Alizadeh, Darya ;
Wang, Dongrui ;
Weist, Michael R. ;
Shepphird, Jennifer K. ;
Brown, Christine E. .
IMMUNOLOGICAL REVIEWS, 2019, 290 (01) :60-84
[5]   Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 [J].
Aktas, Y ;
Yemisci, M ;
Andrieux, K ;
Gürsoy, RN ;
Alonso, MJ ;
Fernandez-Megia, E ;
Novoa-Carballal, R ;
Quiñoá, E ;
Riguera, R ;
Sargon, MF ;
Çelik, HH ;
Demir, AS ;
Hincal, AA ;
Dalkara, T ;
Çapan, Y ;
Couvreur, P .
BIOCONJUGATE CHEMISTRY, 2005, 16 (06) :1503-1511
[6]  
Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]
[7]   Exosomes and Exosome-Inspired Vesicles for Targeted Drug Delivery [J].
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Marazioti, Antonia .
PHARMACEUTICS, 2018, 10 (04)
[8]   Extracellular Matrix and Matrix Receptors in Blood-Brain Barrier Formation and Stroke [J].
Baeten, Kim M. ;
Akassoglou, Katerina .
DEVELOPMENTAL NEUROBIOLOGY, 2011, 71 (11) :1018-1039
[9]   Gene editing for immune cell therapies [J].
Bailey, Stefanie R. ;
Maus, Marcela V. .
NATURE BIOTECHNOLOGY, 2019, 37 (12) :1425-1434
[10]   Simultaneous Blood-Brain Barrier Crossing and Protection for Stroke Treatment Based on Edaravone-Loaded Ceria Nanoparticles [J].
Bao, Qunqun ;
Hu, Ping ;
Xu, Yingying ;
Cheng, Tiansheng ;
Wei, Chenyang ;
Pan, Limin ;
Shi, Jianlin .
ACS NANO, 2018, 12 (07) :6794-6805